Press Release

Gensco® Pharma Partners with IntelGenx to Launch and Commercialize RIZAPORT® (Rizatriptin Oral Film) in the United States

Miami, Florida, December 12, 2018 – Gensco® Pharma, a leading specialty pharmaceutical manufacturer specializing in development and commercialization of prescription transdermal products, today announced the execution of a definitive licensing, development and supply...

Now Available Through Federal Supply Schedule (FSS)

Contract #V797D-70219 The Only FDA-Approved Prescription Hydrogel and 4% Lidocaine HCl for Pain Associated with Wound Healing and Vasculitis FDA Approved #K092086 Astero®, manufactured by Gensco Pharma, is now available through the Federal Supply Schedule. Astero®...

Medicare (CGDP) Gap Announcement

Gensco Pharma Announces Additions to 2017 CGDP on CMS Gensco products will be available to MEDICARE patients in 2017

Gensco Pharma Launches the First Transdermal Medication for Acute Gout Flares

The transdermal route of administration allows for local treatment September 9, 2015 (Miami, FL) – Gensco Pharma launches ColciGel™, a new transdermal medication indicated for the treatment and prophylaxis of acute gout flares in adults. Gout – an extremely painful...

Gensco Pharma Announces LiDORx Copay Program Mobile Platform for Pain Management

Text “Lido to 37500” on your mobile device to receive the benefits of the program Press Release – August 10, 2015: Miami, FL – August 5, 2015 –Gensco Pharma™ (www.genscolabs.com), A Specialty Pharmaceutical Company, announces a new mobile platform...

Gensco Pharma Supports Gout Awareness Day on May 22nd, 2015

Press Release – May 22nd, 2015: National Gout Awareness Day is held every year on May 22. During this day, the Gout & Uric Acid Education Society (GUAES) amplifies its efforts to raise public awareness of gout – an extremely painful form of inflammatory...